Please note:
Meetings held on odd years are organized by the Society for Hematopathology (SH) and meetings held on even years are organized by the European Association for Haematopathology (EA4HP).
| Year | Location | Bone Marrow Symposium | Bone Marrow Workshop | Lymphoma Symposium | Lymphoma Workshop |
|---|---|---|---|---|---|
| 2026 | Berlin, Germany | Application of Artificial Intelligence (AI)-Based Algorithms in Bone Marrow Diagnostics and the Use of AI in Myeloid Neoplasm Classification | Myeloid Neoplasms With Significant Fibrosis (Excluding Classic MPN) Myeloid Neoplasms (Including AML) With Concomitant Clonal Mature T- or NK-Cell Proliferations/T-Cell Lymphomas Hypoplastic MDS and Hypoplastic AML (De Novo) Including Cases Presenting With Germline Disposition |
The Microenvironment of Lymphoma and Lymphoproliferations | Lymphomas With Prominent Immune Microenvironment |
| 2025 | Cincinnati, OH, USA | Hematopathology in the Pediatric and Adolescent / Young Adult Population | |||
| 2024 | Dubrovnik, Croatia | Organization of the Stem-, Committed- and Precursor-cell Bone Marrow Populations: Lessons Learned from Myeloid and Lymphoid Precursor Cell Neoplasms and Mixed Phenotype Acute Leukemias State-of-the-Art: Hemophagocytic Lymphohistiocytosis - Pathogenesis and Pathology Myeloid neoplasms: from Hematology and Pathology Dogmas to Hierarchic Molecular Genetics |
Reactive and Therapy Induced Bone Marrow Changes Linked to Systemic Infectious and Non-Infectious Disorders and MAS/HLH Myeloid Neoplasms with Evidence of the Additive and/or Cumulative Effect of Molecular Genetic Alterations that have “Paved the Way” to a Specific Disease Category, Subcategory or Entity Myeloid and Lymphoid Early/Undifferentiated Precursor Cell Neoplasms and Mixed Phenotype Acute Leukemias |
Novel Mechanisms in Lymphomagenesis | Exploring the Boundaries of Reactive and Neoplastic Lymphoproliferations |
| 2023 | Houston, TX, USA | Progress in T- and NK-cell Lymphomas/Leukemias | |||
| 2022 | Florence, Italy | Novel Frontiers in Molecular Diagnosis of Myeloid Neoplasms: Biomarkers and Integrative Prognostic Models in Myeloid Diseases | Paediatric myeloid neoplasms and related diseases AML of ambiguous lineage and other cases of acute leukaemia hard to classify Adult myelofibrotic myeloid neoplasms |
Novel Frontiers in Molecular Diagnosis of Lymphoma and Emerging Disease Entities | Provisional and Emerging Disease Entities |
| 2021 | Philadelphia, PA, USA | Transformation and Transdifferentiation in Hematolymphoid Malignancies Click here to view the 2021 Workshop Proceedings |
|||
| 2020 | Virtual | Overlaps, Borderlines and Mimics | Pediatric Myeloid Neoplasms and Related Diseases, AML of Ambiguous Linage, Other Cases of Acute Leukemia Hard to Classify, Myelofibrotic Myeloid Neoplasms | Overlaps, Borderlines and Mimics: Understanding Lymphoma Biology is Key to Pathological Classification and Treatment | Classic Hodgkin Lymphoma and its Bimics, Spectrum of Mediastinal LBCL, Unusual Patterns of NLPHL, the Spectrum of Aggressive B-cell Lymphomas other than DLBCL, Lymphomas with Plasmablastic Mmorphology |
| 2019 | Pheonix, AZ, USA | Addressing the Challenges of Eosinophilia & Mastocytosis | |||
| 2018 | Edinburgh, Scotland | ALL and reactive lesions, T-NHL and Hodgkin Lymphoma, Aggressive B-NHL | ALL and reactive lesions, T-NHL and Hodgkin Lymphoma, Aggressive B-NHL | The Impact of Intrinsic and Extrinsic Factors in Site-Specific Lymphoproliferations | Extranodal Lymphoproliferations, Including Immune Privileged Sites |
| 2017 | Chicago, IL, USA | Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms | |||
| 2016 | Basel, Switzerland | Aggressive Malignancies of the 'Other Cells' of the Bone Marrow: Histiocytes, Dendritic Cells and Mast Cells | Aggressive Malignancies of the 'Other Cells' of the Bone Marrow: Histiocytes, Dendritic Cells and Mast Cells | Aggressive Lymphoid and Accessory/Histiocytic Cell Neoplasms | Aggressive Lymphoid and Accessory/Histiocytic Cell Neoplasms |
| 2015 | Long Beach, CA, USA | Immunodeficiency and Dysregulation Related LPDs | |||
| 2014 | Istanbul, Turkey | Small B-cell Lymphoid Neoplasms in Bone Marrow: Diagnostic Advances | Diagnostic Difficulties in CLL, Bone Marrow Manifestations of LPL, MZL, SRPL, HCL-v and HCL, Small B-cell Lymphomas in Bone Marrow Multiclonality and Composite Lymphomas | Redefining the Spectrum of Small B-cell Lymphomas in Light of Current Technology | Small B-cell Lymphoma |
| 2013 | Houston, Texas, USA | Progress in Acute Myeloid Leukemia, Myelodysplastic Syndromes and Acute Lymphoblastic Leukemia: Classification and Molecular Pathogenesis | |||
| 2012 | Lisbon, Portugal | Reactive and Neoplastic T-cell Proliferations in the Bone Marrow | Aggressive Mature T/NK Cell Lymphomas, T-cell Prolymphocytic Leukaemia and Other T-cell proliferations and Bone Marrow Failure | Peripheral T and NK-cell Lymphomas and Their Mimics; Taking a Step Forward | Peripheral T and NK-cell Lymphomas and Their Mimics |
| 2011 | Los Angeles, California, USA | Cutaneous Lymphoma | |||
| 2010 | Uppsala, Sweden | From Molecular and Histopathological Bone Marrow Studies to Therapy | Unusual Acute Leukemias, Transformation of MPN and MDS, Myelosarcomas and Other Cases | Frontiers in Diagnosing Lymphoma – Early Lesions, Molecular Pathogenesis and Targeted Therapy | Early Lesions in Lymphoid Neoplasia |